« February 2007 | Main | April 2007 »

Mar30
Tequila Raw Ingredient as Drug-carrier for Therapeutics against Colon Diseases

Blue agave is a fruit used to make tequila. Natural compounds from this fruit have been found in earlier laboratory studies to be potentially effective in the delivery of drugs to the colon than conventional drug-carriers.

Such were the findings of chemists at the University of Guadalajara in Mexico which could lead to improved treatments for ulcerative colitis, irritable bowel syndrome, cancer, Crohn's disease and other colon diseases.

jose_cuervo_tequila.jpgAccording to the study’s researchers:

The tequila compounds, a class of polysaccharides known as fructans, were developed by the scientists in Mexico into tiny microspheres that are capable of carrying existing drugs that are used to treat colon diseases.

Because the compounds resist destruction in the stomach, they could allow more of the drugs to reach the colon intact and improve their effectiveness.

The study’s findings have recently been presented at the 233rd national meeting of the American Chemical Society.

Find more details from the full report.

[photo credit: andrew.stottsan.net]

Mar30
Pfizer Initiates Glaucoma Clinical Trial of PF-03187207 under Collaboration with NicOx
OseoNews.com: Research on Dental Implants a Click Away
Mar29
Carrington Laboratories and International Vaccine Institute Collaborates on Sublingual Vaccines
New Long Acting Drug For Erectile Dysfunction: Dong-A PharmTech’s Udenafil, Passed Phase 2b Clinical Trial
Adams Respiratory Therapeutics Collaborates With MonoSol Rx, LLC
StormBio and Imperial Innovations Collaborates on Pandemic Influenza Treatment
Nuvelo’s rNAPc2 Received USFDA Fast Track Designations as First- and Second-Line Treatment of Metastatic Colorectal Cancer
REMICADE® Recommended for Approval by EU CHMP for Biologic Treatment of Pediatric Crohn's Disease
Mar27
First Therapeutic Vaccine for Cancer Treatment, Approved by USDA in Canines
New High Blood Pressure Drug Tekturna®, Works Better Adjunct to Diovan®
Schering-Plough and Merck Collaborates to Make New Cholesterol-lowering Drug
EMEA Recommends Oral Cancer Drug REVLIMID® as Treatment for Multiple Myeloma
Mar26
Manufacturing Agreement with SAFC for Lead anticancer agent Cloretazine® (VNP40101M), Extended by Vion Pharmaceuticals
Lilly Invests Additional $50 Million to Global Tuberculosis Partnership
Mild Hyperthermia Enhances Anti-tumor Effects of Alfacell's ONCONASE®
Study Backs Martek’s life’sDHA™’s Ability to Lower Diastolic Blood Pressure
Mar25
China Biopharma Signed Distribution Agreement with Takeda Pharmaceutical
Chromos and Pain Thearapeutics Entered into Cell Line Engineering Agreement
DoD Awarded Grant to Cleveland BioLabs for Development of Radiation Countermeasure Compound, Protectan CBLB502
MINRAD’s Sevoflurane, Approved in Japan
CTI Filed USFDA SPA for Phase III Trial of XYOTAX™ in Women Lung Cancer
Mar24
Preclinical Data of Amicus Therapeutics’ Plicera™, Promising against Gaucher Disease
Promising Research Data Suggest Potential of ImmuneRegen BioSciences’ Homspera™ as Co-therapeutic Agent
NOXAFIL® (Posaconazole) is Recommended by New Cancer Practice Guidelines for Antifungal Prophylaxis in Certain High-Risk Patients
WRAIR and USAMMDA Collaborates with Sigma-Tau Pharmaceuticals for New Treatment for Severe Malaria
Mar23
Blame it on Grey's Anatomy
DecisionView Entered Multi-year Agreement with GlaxoSmithKline
Mar20
Evotec AG and Boehringer Ingelheim Entered Alzheimer’s Disease Collaboration
University of British Columbia Licensed Clinical Stage Diabetes Therapy to Akesis Pharmaceuticals
Medivation, Inc.’s Dimebon™ Passed Efficacy Trial in Alzheimer’s Disease Patients
Mar18
Micromet and TRACON Pharmaceuticals Entered Exclusive Worldwide License Agreement for the Development and Commercialization of Humanized Antibody against Cancer
Exelixis Submitted IND for Candidate Anti-cancer Compound XL147
Alexion Pharma’s Soliris™, First Therapy for Paroxysmal Nocturnal Hemoglobinuria (PNH) Approved by the USFDA
Mar17
Abeille Pharma’s Transdermal Patch for Emesis, Licensed to SymBio Pharma for Commercialization in Japan and Pacific Rim Countries
Aida Pharma Subsidiary Commenced Preclinical Study of Vasostatin-Apo2L, Potential Anti-Cancer Therapy
GSK Expands Patient Assistance Program to Include Breast Cancer Drug TYKERB®
Mar16
SPA for Phase III Clinical Trial of Pixantrone in non- Hodgkin's Lymphoma (NHL) Submitted by CTI to USFDA
Lev Pharmaceuticals’ C1-esterase inhibitor (C1-INH) Passed Pivotal Phase III Trial for Hereditary Angioedema (HAE)
Advanced Life Sciences’ Cethromycin Granted USFDA Orphan Drug Status for Anthrax
USFDA Accepted Adams Respiratory Therapeutics' NDA Submission for Prescription Cough Suppressant
CeNeRx BioPharma’s Third Generation RIMA Antidepressant -Tyrima® - Passed Phase I Clinical Trial
Mar15
Post-Marketing Studies of AMITIZA® Initiated by Sucampo Pharma in Renal or Hepatic Impaired Subjects
Array BioPharma and VentiRx Pharmaceuticals Entered License Agreement
Virax Holdings Licensed Transgene Co-X-Gene™ Technology to Two Transgene Immunotherapeutic Products
Mar14
Interesting Finds: Pharma-related Blog Posts 4
Preliminary Results of Chemokine Therapeutics’s CTCE-9908 Phase Ib/II Clinical Trial in Late Stage Cancer Patients, Demonstrated Positive Data
Schering-Plough Will Acquire Organon BioSciences
Oxford BioMedical Will Acquire Oxxon Therapeutics
Mar12
La Jolla Pharmaceutical’s Riquent® Passed Interim Phase 3 Trial in Lupus Patients
Supplemental New Drug Application (sNDA) for Pediatric Doses of Tamiflu®, Submitted by Roche to USFDA
Mar 9
Interesting Finds: Pharma-related Blog Posts 3
Use of InflameAway™-Celadrin® Significantly Improved Knee Function and Joint Mobility
Use of HPV Vaccine, Endorsed by National Medical Association (NMA)
USFDA Approved 5 New Indications of Lipitor® in Heart Disease Patients
Novel Cystic Fibrosis Therapy Moli1901, Passed Phase II Clinical Trial
Mar 7
LAB International’s Fentanyl TAIFUN® Passed Open-label Phase IIb Trial
Hovione’s Inhaler Technology Licensed to Sankyo and Biota for Influenza Drug Delivery
Eli Lilly To Acquire Hypnion, Inc.
Phase 3 INSPIRE Trial of Actimmune® in Idiopathic Pulmonary Fibrosis (IPF) Discontinued by Intermune, Inc.
Mar 6
Myriad’s Flurizan™ Passed Phase 2 Follow-up Study in Mild Alzheimer's Disease Patients
Iomai’s Vaccine Patch for Travelers' Diarrhea, Passed Challenge Study
Transition Therapeutics’ E1-I.N.T.™ Passed Phase IIa Clinical Trials in Type 1 and Type 2 Diabetes Patients
Memory Pharma’s MEM 1003 Failed Phase 2a Bipolar Disorder Clinical Trial
Mar 5
Dermatrends, Inc. Partners with Teikoku Pharma USA to Develop Transdermal Formula of Anti-Psychotic Drugs
Insert Therapeutics Agreed to Partner with R&D-Biopharmaceuticals To Develop New Anti-Cancer Drugs
PREVENAR™’s Extended Indication to Include Pneumonia and Otitis Media, Received Positive Opinion from EU Committee
Pharmion Corp.’s Marketing Authorization Application (MAA) for Thalidomide Pharmion (thalidomide), Accepted by the EMEA
Mar 4
Astellas' Vaprisol®, USFDA-approved for the Treatment of Hypervolemic Hyponatremia
Idenix Pharma’s SEBIVO® (Telbivudine) Approved in China
Mar 3
2007 BIO International Convention
Mar 2
RISPERDAL®, Granted Pediatric Exclusivity by USFDA
MAP Pharmaceuticals’ Inhaled Migraine Drug Candidate Passed Phase 2 Clinical Trials
Mar 1
Over 300 Medicines against Rare Diseases, In Development
Evotec and Interprotein Collaborates to Develop Interleukin 6 Inhibitors to Treat Inflammatory Diseases
First Medication for Treatment and Prevention of Vomiting in Dogs, Approved by the USFDA

« February 2007 | Main | April 2007 »

Advertise

Watch the Digital Health Revolution


sponsored ads



Incredible Hall of Acclaim.

subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

WebMetricsGuru

TheInsurancePolicy

MarketingBlurb